Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation

British Journal of Ophthalmology

Volumn 93, Issue 8, 2009, Pages 1075-1080

  Bachmann, B O ^a   Luetjen Drecoll, E ^a   Bock, F ^a   Wiegand, S J ^b   Hos, D ^a   Dana, R ^c   Kruse, F E ^a   Cursiefen, C ^a,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA VASCULARIZATION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; KERATOPLASTY; LYMPH VESSEL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; ANIMALS; CORNEA; CORNEAL NEOVASCULARIZATION; FEMALE; GRAFT SURVIVAL; KERATOPLASTY, PENETRATING; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68049098957     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.145128     Document Type: Article

References (25)

1. Epstein RJ, Stulting RD, Hendricks RL, et al. Corneal neovascularization. Pathogenesis and inhibition. Cornea 1987;6:250-257
2. Cursiefen C, Kruse FE. New aspects of corneal angiogenesis. In: Krieglstein GK, Weinreb RN, eds. Essentials in ophthalmology. Berlin: Springer, 2006.
3. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 1998;43:245-269
4. Bachmann BO, Bock F, Wiegand SJ, et al. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol 2008;126:71-77
5. Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 2004;45:2666-2673 (Pubitemid 38998863)
6. Cursiefen C, Maruyama K, Jackson DG, et al. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 2006;25:443-447 (Pubitemid 44620130)
7. Cursiefen C, Schlotzer-Schrehardt U, Kuchle M, et al. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci 2002;43:2127-2135 (Pubitemid 34700638)
8. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992;54:694-704.
9. She SC, Steahly LP, Moticka EJ. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg 1990;21:781-785
10. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004;113:1040-1050 (Pubitemid 38544126)
11. Bock F, Onderka J, Hos D, et al. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp Eye Res 2008;87:462-470
12. Holash J, Davis S, Papadopoulos N, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A 2002;99:11393-11398 (Pubitemid 34920936)
13. Hamrah P, Huq SO, Liu Y, et al. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol 2003;74:172-178 (Pubitemid 38040413)
14. Hamrah P, Liu Y, Zhang Q, et al. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci 2003;44:581-589 (Pubitemid 36159702)
15. Liu Y, Hamrah P, Zhang Q, et al. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med 2002;195:259-268 (Pubitemid 34461269)
16. Yamagami S, Dana MR, Tsuru T. Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea 2002;21:405-409 (Pubitemid 34450478)
17. Plskova J, Holan V, Filipec M, et al. Lymph node removal enhances corneal graft survival in mice at high risk of rejection. BMC Ophthalmol 2004;4:3. (Pubitemid 38760874)
18. Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci 1995;36:2176-2185
19. Sano Y, Ksander BR, Streilein JW. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci 1997;38:1130-1138
20. Williams KA, Muehlberg SM, Lewis RF, et al. How successful is corneal transplantation? A report from the Australian Corneal Graft Register. Eye 1995;9:219-227
21. Williams KA, Muehlberg SM, Lewis RF, et al. Graft survival after corneal transplantation: role of factors with the potential for recipient presensitisation. The Australian Corneal Graft Registry (ACGR). Transplant Proc 1995;27:2141-2142
22. Williams KA, Muehlberg SM, Lewis RF, et al. Long-term outcome in corneal allotransplantation. The Australian Corneal Graft Registry. Transplant Proc 1997;29:983.
23. Yamagami S, Dana MR. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 2001;42:1293-1298 (Pubitemid 32381972)
24. Sanfilippo F, MacQueen JM, Vaughn WK, et al. Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation. N Engl J Med 1986;315:29-35. (Pubitemid 16093248)
25. Hos D, Bachmann BO, Bock F, et al. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis. Exp Eye Res 2008;87:427-432